Nifty

:

23719.30

Sensex

:

75415.35

64.60 (0.27%)
231.99 (0.31%)

Login

Nifty
Sensex

:
:

23719.30
75415.35

64.60 (0.27%)
231.99 (0.31%)

Syncom Formulations (India) Ltd.

Pharmaceuticals & Drugs

Rating :

61/99

BSE: 524470 | NSE: SYNCOMF

Watchlist

NSE BSE

14.34

22-May-2026

Open
High
Low
Previous Close

14.39
14.49
14.19
14.26

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1609385
23087184.68
23.49
10.21

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,347.02
19.45
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,342.58
N/A
3.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.72
13.59
27.52

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.50
7.06
22.16

PAT CAGR (%)

10 Years
5 Years
3 Years

16.91
10.87
35.05

P:E (Median)

8 Years
5 Years
3 Years

37.15
53.77
40.60

P:BV (Average)

8 Years
5 Years
3 Years

1.72
2.68
4.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.63
32.21
26.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 134.00 148.46 -9.74% 114.59 127.03 -9.79% 121.43 101.49 19.65% 116.55 86.83 34.23%
Expenses 112.51 130.99 -14.11% 93.42 112.43 -16.91% 102.71 89.56 14.68% 100.77 76.36 31.97%
EBITDA 21.49 17.47 23.01% 21.17 14.60 45.00% 18.72 11.93 56.92% 15.77 10.47 50.62%
EBIDTM 16.04% 11.77% 18.48% 11.49% 15.42% 11.75% 13.54% 12.06%
Other Income 14.23 6.90 106.23% 5.48 3.83 43.08% 5.23 4.18 25.12% 6.02 1.31 359.54%
Interest 0.37 0.09 311.11% 0.25 0.21 19.05% 0.25 0.16 56.25% 0.24 0.39 -38.46%
Depreciation 2.48 1.29 92.25% 1.36 1.31 3.82% 1.35 1.30 3.85% 1.34 1.30 3.08%
PBT 32.86 23.01 42.81% 25.05 16.90 48.22% 22.36 14.65 52.63% 20.26 10.10 100.59%
Tax 8.29 5.51 50.45% 6.19 4.11 50.61% 5.52 3.70 49.19% 4.53 2.47 83.40%
PAT 24.58 17.50 40.46% 18.86 12.79 47.46% 16.84 10.95 53.79% 15.73 7.63 106.16%
PATM 18.34% 11.79% 16.46% 10.07% 13.87% 10.79% 13.50% 8.79%
EPS 0.26 0.19 36.84% 0.20 0.14 42.86% 0.18 0.12 50.00% 0.17 0.08 112.50%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 135.41 148.88 -9.05% 115.14 127.53 -9.72% 121.72 102.31 18.97% 116.90 87.25 33.98%
Expenses 113.40 131.12 -13.51% 93.93 112.80 -16.73% 103.32 90.15 14.61% 101.09 76.80 31.63%
EBITDA 22.01 17.75 24.00% 21.21 14.73 43.99% 18.40 12.16 51.32% 15.81 10.45 51.29%
EBIDTM 16.26% 11.92% 18.42% 11.55% 15.12% 11.89% 13.52% 11.98%
Other Income 14.55 6.94 109.65% 5.50 4.04 36.14% 5.25 4.15 26.51% 6.04 1.34 350.75%
Interest 0.38 0.12 216.67% 0.26 0.20 30.00% 0.27 0.16 68.75% 0.25 0.39 -35.90%
Depreciation 2.48 1.29 92.25% 1.36 1.31 3.82% 1.35 1.30 3.85% 1.34 1.30 3.08%
PBT 33.70 23.30 44.64% 25.09 17.26 45.37% 22.04 14.85 48.42% 20.29 10.10 100.89%
Tax 8.53 5.61 52.05% 6.18 4.26 45.07% 5.44 3.74 45.45% 4.54 2.47 83.81%
PAT 25.18 17.69 42.34% 18.91 13.00 45.46% 16.60 11.11 49.41% 15.75 7.63 106.42%
PATM 18.59% 11.89% 16.42% 10.19% 13.64% 10.86% 13.48% 8.75%
EPS 0.27 0.19 42.11% 0.20 0.14 42.86% 0.18 0.12 50.00% 0.17 0.08 112.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 486.57 462.85 258.36 224.64 219.66 244.81 205.51 186.77 158.63 184.82 183.90 Net Sales Growth 4.91% 79.15% 15.01% 2.27% -10.27% 19.12% 10.03% 17.74% -14.17% 0.50% Cost Of Goods Sold 283.73 267.02 116.32 101.08 105.70 120.38 117.67 107.49 80.82 102.80 106.54 Gross Profit 202.84 195.83 142.04 123.56 113.96 124.42 87.84 79.28 77.81 82.03 77.36 GP Margin 41.69% 42.31% 54.98% 55.00% 51.88% 50.82% 42.74% 42.45% 49.05% 44.38% 42.07% Total Expenditure 409.41 409.34 230.51 204.76 199.63 206.76 188.72 174.93 146.93 168.42 167.23 Power & Fuel Cost - 5.62 6.13 5.31 4.38 3.84 3.93 3.63 3.40 3.01 2.69 % Of Sales - 1.21% 2.37% 2.36% 1.99% 1.57% 1.91% 1.94% 2.14% 1.63% 1.46% Employee Cost - 50.56 33.57 24.44 20.73 18.24 15.80 15.21 14.77 14.33 13.48 % Of Sales - 10.92% 12.99% 10.88% 9.44% 7.45% 7.69% 8.14% 9.31% 7.75% 7.33% Manufacturing Exp. - 42.51 41.34 44.08 36.93 42.97 35.87 30.15 29.64 26.74 27.01 % Of Sales - 9.18% 16.00% 19.62% 16.81% 17.55% 17.45% 16.14% 18.68% 14.47% 14.69% General & Admin Exp. - 23.91 19.73 15.00 14.06 9.13 8.73 9.00 9.15 9.13 8.36 % Of Sales - 5.17% 7.64% 6.68% 6.40% 3.73% 4.25% 4.82% 5.77% 4.94% 4.55% Selling & Distn. Exp. - 19.17 12.81 14.29 17.32 11.91 6.42 9.14 8.84 12.09 8.90 % Of Sales - 4.14% 4.96% 6.36% 7.88% 4.86% 3.12% 4.89% 5.57% 6.54% 4.84% Miscellaneous Exp. - 0.55 0.61 0.56 0.50 0.29 0.31 0.31 0.31 0.31 8.90 % Of Sales - 0.12% 0.24% 0.25% 0.23% 0.12% 0.15% 0.17% 0.20% 0.17% 0.14% EBITDA 77.15 53.51 27.85 19.88 20.03 38.05 16.79 11.84 11.70 16.40 16.67 EBITDA Margin 15.86% 11.56% 10.78% 8.85% 9.12% 15.54% 8.17% 6.34% 7.38% 8.87% 9.06% Other Income 30.96 17.19 13.10 14.61 11.99 7.14 5.22 5.08 4.44 3.08 2.67 Interest 1.11 0.85 4.45 3.40 1.93 0.48 0.61 0.25 0.30 0.36 0.14 Depreciation 6.53 5.19 4.72 4.54 3.95 4.03 4.06 4.00 3.73 3.12 3.00 PBT 100.53 64.65 31.78 26.55 26.15 40.67 17.34 12.68 12.12 16.00 16.20 Tax 24.53 15.79 8.14 6.50 6.39 11.53 3.04 1.59 3.37 5.34 5.75 Tax Rate 24.40% 24.42% 25.63% 24.47% 24.42% 28.33% 17.58% 12.54% 28.04% 33.40% 35.71% PAT 76.01 48.87 23.62 20.07 19.79 29.17 14.25 11.09 8.65 10.65 10.36 PAT before Minority Interest 76.01 48.87 23.62 20.07 19.79 29.17 14.25 11.09 8.65 10.65 10.36 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.62% 10.56% 9.14% 8.93% 9.01% 11.92% 6.93% 5.94% 5.45% 5.76% 5.63% PAT Growth 55.54% 106.90% 17.69% 1.41% -32.16% 104.70% 28.49% 28.21% -18.78% 2.80% EPS 0.81 0.52 0.25 0.21 0.21 0.31 0.15 0.12 0.09 0.11 0.11

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Net Sales 489.17 465.01 263.39 224.25 219.66 184.82 183.90 173.39 Net Sales Growth 4.98% 76.55% 17.45% 2.09% 18.85% 0.50% 6.06% Cost Of Goods Sold 284.27 267.47 117.65 100.65 105.70 102.80 106.54 84.41 Gross Profit 204.90 197.55 145.74 123.60 113.96 82.03 77.36 88.98 GP Margin 41.89% 42.48% 55.33% 55.12% 51.88% 44.38% 42.07% 51.32% Total Expenditure 411.74 410.88 233.74 204.35 199.63 168.27 167.23 155.18 Power & Fuel Cost - 5.62 6.13 5.31 4.38 3.01 2.69 2.76 % Of Sales - 1.21% 2.33% 2.37% 1.99% 1.63% 1.46% 1.59% Employee Cost - 50.56 33.57 24.44 20.73 14.45 13.48 13.38 % Of Sales - 10.87% 12.75% 10.90% 9.44% 7.82% 7.33% 7.72% Manufacturing Exp. - 42.51 41.34 44.08 36.93 26.74 27.01 33.14 % Of Sales - 9.14% 15.70% 19.66% 16.81% 14.47% 14.69% 19.11% General & Admin Exp. - 23.97 19.77 15.02 14.06 8.86 8.36 7.54 % Of Sales - 5.15% 7.51% 6.70% 6.40% 4.79% 4.55% 4.35% Selling & Distn. Exp. - 20.20 14.68 14.29 17.32 12.09 8.90 13.72 % Of Sales - 4.34% 5.57% 6.37% 7.88% 6.54% 4.84% 7.91% Miscellaneous Exp. - 0.55 0.61 0.56 0.50 0.31 0.26 0.23 % Of Sales - 0.12% 0.23% 0.25% 0.23% 0.17% 0.14% 0.13% EBITDA 77.43 54.13 29.65 19.90 20.03 16.55 16.67 18.21 EBITDA Margin 15.83% 11.64% 11.26% 8.87% 9.12% 8.95% 9.06% 10.50% Other Income 31.34 17.43 13.53 14.60 11.99 2.79 2.67 1.98 Interest 1.16 0.86 4.47 3.40 1.93 0.33 0.14 0.29 Depreciation 6.53 5.19 4.72 4.54 3.95 3.12 3.00 3.40 PBT 101.12 65.51 33.98 26.56 26.15 15.89 16.20 16.49 Tax 24.69 16.08 8.64 6.50 6.39 5.34 5.75 5.88 Tax Rate 24.42% 24.54% 25.44% 24.46% 24.42% 33.63% 35.71% 37.62% PAT 76.44 49.43 25.31 20.07 19.79 10.53 10.36 9.76 PAT before Minority Interest 76.44 49.43 25.31 20.07 19.79 10.53 10.36 9.76 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.63% 10.63% 9.61% 8.95% 9.01% 5.70% 5.63% 5.63% PAT Growth 54.64% 95.30% 26.11% 1.41% 87.94% 1.64% 6.15% EPS 0.81 0.53 0.27 0.21 0.21 0.11 0.11 0.10

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 339.90 286.45 256.01 222.22 187.58 145.65 132.62 121.94 114.14 108.70 Share Capital 94.00 94.00 94.00 86.25 79.00 78.07 78.07 78.07 78.07 78.07 Total Reserves 245.90 192.45 162.01 130.94 98.84 67.58 54.56 43.88 36.08 30.63 Non-Current Liabilities 11.81 10.00 8.66 7.76 7.36 7.11 7.57 9.37 8.33 6.27 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.17 3.30 2.69 1.71 1.39 1.21 0.74 0.69 0.60 0.00 Current Liabilities 60.38 97.28 112.27 78.26 96.70 31.18 35.82 42.70 56.36 65.68 Trade Payables 42.72 14.23 20.41 13.79 29.30 20.30 21.16 22.31 32.26 46.94 Other Current Liabilities 7.09 5.72 6.07 2.83 3.12 3.36 1.22 3.40 5.85 3.67 Short Term Borrowings 4.04 71.65 83.18 57.79 62.09 2.15 8.67 12.45 12.45 5.62 Short Term Provisions 6.53 5.69 2.61 3.85 2.19 5.38 4.76 4.54 5.80 9.46 Total Liabilities 412.09 393.73 376.94 308.24 291.64 183.94 176.01 174.01 178.83 180.65 Net Block 77.57 72.42 43.40 46.61 44.32 45.98 48.35 57.55 55.04 45.85 Gross Block 145.62 135.66 101.92 100.68 95.18 92.91 91.31 97.63 91.98 82.41 Accumulated Depreciation 68.05 63.25 58.53 54.07 50.86 46.92 42.96 40.08 36.94 36.56 Non Current Assets 142.22 128.86 196.17 168.44 101.81 94.54 94.69 92.60 92.29 89.10 Capital Work in Progress 0.00 0.00 25.59 6.20 0.38 0.00 0.00 0.64 0.25 4.72 Non Current Investment 3.65 2.52 1.87 1.93 1.17 0.63 1.51 2.04 1.28 23.47 Long Term Loans & Adv. 1.20 1.01 2.26 2.25 1.10 0.79 4.34 0.95 5.89 15.05 Other Non Current Assets 12.47 5.58 75.73 64.33 7.70 0.00 0.28 0.00 0.15 0.00 Current Assets 269.88 264.87 180.77 139.80 189.84 89.40 81.32 81.41 86.55 91.55 Current Investments 89.22 63.70 62.26 41.40 9.89 0.00 0.00 0.00 0.00 0.00 Inventories 41.29 21.08 20.77 19.51 22.56 16.07 13.72 11.04 10.01 15.47 Sundry Debtors 106.94 93.21 75.14 67.55 74.82 43.34 41.33 37.70 45.99 46.00 Cash & Bank 0.69 67.83 8.58 0.39 64.20 8.57 7.87 6.27 7.27 5.69 Other Current Assets 31.73 1.30 4.46 2.73 18.37 21.42 18.40 26.40 23.27 24.39 Short Term Loans & Adv. 28.50 17.75 9.56 8.23 11.36 16.34 12.27 22.42 13.52 18.41 Net Current Assets 209.49 167.59 68.50 61.54 93.14 58.22 45.50 38.71 30.18 25.87 Total Assets 412.10 393.73 376.94 308.24 291.65 183.94 176.01 174.01 178.84 180.65

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Shareholder's Funds 342.16 288.14 256.01 222.22 117.35 108.70 100.22 Share Capital 94.00 94.00 94.00 86.25 78.07 78.07 78.07 Total Reserves 248.16 194.14 162.01 130.94 39.29 30.63 22.16 Non-Current Liabilities 11.81 10.00 8.66 7.76 7.73 6.27 5.62 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 4.17 3.30 2.69 1.71 0.00 0.00 0.00 Current Liabilities 61.78 108.76 113.16 78.26 58.84 65.69 36.66 Trade Payables 42.80 24.14 20.45 13.79 32.27 46.94 19.92 Other Current Liabilities 7.75 6.26 6.91 2.83 5.84 3.67 1.63 Short Term Borrowings 4.58 72.49 83.18 57.79 12.45 5.62 6.08 Short Term Provisions 6.66 5.86 2.62 3.85 8.27 9.46 9.04 Total Liabilities 415.75 406.90 377.83 308.24 183.92 180.66 142.50 Net Block 77.57 72.42 43.40 46.61 55.04 45.85 45.78 Gross Block 145.62 135.66 101.92 100.68 91.98 82.41 80.43 Accumulated Depreciation 68.05 63.25 58.53 54.07 36.94 36.56 34.65 Non Current Assets 143.31 129.88 196.14 168.44 97.38 88.99 58.91 Capital Work in Progress 0.00 0.00 25.59 6.20 0.25 4.72 0.00 Non Current Investment 3.62 2.49 1.84 1.93 35.91 23.37 6.38 Long Term Loans & Adv. 1.20 1.01 2.26 2.25 6.18 15.05 6.75 Other Non Current Assets 13.59 6.63 75.73 64.33 0.00 0.00 0.00 Current Assets 272.44 277.01 181.69 139.80 86.54 91.66 83.59 Current Investments 89.22 63.70 62.26 41.40 0.00 0.00 0.00 Inventories 41.33 21.08 21.20 19.51 10.01 15.47 10.94 Sundry Debtors 107.55 103.30 75.51 67.55 45.99 46.00 31.16 Cash & Bank 0.71 67.87 8.63 0.39 6.52 5.69 6.77 Other Current Assets 33.63 1.48 4.46 2.73 24.01 24.50 34.72 Short Term Loans & Adv. 30.14 19.59 9.63 8.23 17.53 18.41 25.47 Net Current Assets 210.66 168.26 68.53 61.54 27.70 25.98 46.93 Total Assets 415.75 406.89 377.83 308.24 183.92 180.65 142.50

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 23.31 -5.94 10.50 16.33 -2.06 5.86 4.33 -1.60 16.90 24.07 PBT 64.65 31.78 26.55 26.15 40.67 17.34 12.68 12.12 16.00 16.10 Adjustment -10.97 -3.27 -6.12 -7.16 -2.10 -1.05 -0.74 -0.28 0.22 1.14 Changes in Working Capital -15.92 -26.87 -3.28 3.58 -29.34 -5.99 -4.17 -10.37 4.71 12.29 Cash after chg. in Working capital 37.77 1.64 17.14 22.57 9.24 10.30 7.77 1.47 20.94 29.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.45 -7.58 -6.65 -6.25 -11.30 -4.43 -3.44 -3.07 -4.03 -5.35 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.10 Cash From Investing Activity -18.38 83.83 -44.97 -27.07 -75.35 1.51 2.44 -2.16 -8.43 -22.74 Net Fixed Assets -9.96 -8.15 -20.63 -11.32 -2.65 -1.60 6.96 -6.04 -5.10 -6.70 Net Investments -26.65 -2.09 -20.80 -32.27 -10.43 0.88 0.53 -0.76 22.19 -16.99 Others 18.23 94.07 -3.54 16.52 -62.27 2.23 -5.05 4.64 -25.52 0.95 Cash from Financing Activity -67.59 -15.37 35.00 8.29 71.96 -6.52 -0.18 -2.05 -2.09 -2.40 Net Cash Inflow / Outflow -62.66 62.52 0.53 -2.45 -5.46 0.86 6.59 -5.81 6.38 -1.08 Opening Cash & Equivalents 63.35 0.83 0.30 2.75 8.21 7.35 0.76 6.57 0.19 6.77 Closing Cash & Equivalent 0.69 63.35 0.83 0.30 2.75 8.21 7.35 0.76 6.57 5.69

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 23.44 -5.96 10.53 16.33 13.84 24.07 0.08 PBT 65.51 33.98 26.56 26.15 15.88 16.10 16.49 Adjustment -11.19 -3.48 -6.11 -7.16 0.71 1.14 2.59 Changes in Working Capital -16.13 -28.37 -3.26 3.58 1.29 12.29 -12.51 Cash after chg. in Working capital 38.18 2.13 17.18 22.58 17.88 29.53 6.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.74 -8.08 -6.65 -6.25 -4.03 -5.35 -5.64 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -0.01 -0.10 -0.86 Cash From Investing Activity -18.20 83.02 -44.95 -27.07 -17.68 -22.74 0.74 Net Fixed Assets -9.96 -8.15 -20.63 -14.65 -5.10 -6.70 Net Investments -26.65 -2.09 -20.80 -42.05 22.19 -16.99 Others 18.41 93.26 -3.52 29.63 -34.77 0.95 Cash from Financing Activity -67.90 -14.56 35.00 8.29 4.67 -2.40 0.68 Net Cash Inflow / Outflow -62.67 62.50 0.58 -2.45 0.83 -1.08 1.50 Opening Cash & Equivalents 63.38 0.88 0.30 2.75 5.69 6.77 5.28 Closing Cash & Equivalent 0.71 63.38 0.88 0.30 6.52 5.69 6.77

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 3.62 3.05 2.72 2.52 2.25 1.87 1.70 1.56 1.46 1.39 ROA 12.13% 6.13% 5.86% 6.60% 12.27% 7.92% 6.34% 4.90% 5.93% 6.41% ROE 15.61% 8.71% 8.48% 10.02% 18.04% 10.24% 8.71% 7.33% 9.56% 9.91% ROCE 18.66% 10.39% 9.68% 10.61% 20.72% 12.39% 9.37% 9.43% 13.58% 14.72% Fixed Asset Turnover 3.29 2.17 2.22 2.24 2.60 2.23 1.98 1.67 2.12 2.28 Receivable days 78.92 118.92 115.92 118.29 88.09 75.19 77.22 96.24 90.83 75.88 Inventory Days 24.59 29.57 32.72 34.95 28.80 26.46 24.19 24.20 25.15 25.97 Payable days 38.93 54.35 61.75 74.40 75.18 40.43 46.30 70.08 91.34 73.89 Cash Conversion Cycle 64.59 94.14 86.89 78.83 41.70 61.22 55.12 50.35 24.64 27.96 Total Debt/Equity 0.01 0.25 0.32 0.27 0.35 0.01 0.07 0.10 0.11 0.05 Interest Cover 77.05 8.14 8.81 14.58 86.35 29.18 52.62 41.40 45.48 119.10

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 3.64 3.07 2.72 2.52 1.50 1.39 1.28 1.22 1.12 ROA 12.02% 6.45% 5.85% 8.04% 5.78% 6.41% 6.82% 6.95% 4.54% ROE 15.69% 9.30% 8.48% 11.83% 9.32% 9.91% 9.99% 10.19% 6.45% ROCE 18.77% 10.98% 9.68% 13.72% 13.28% 14.72% 15.55% 15.29% 10.00% Fixed Asset Turnover 3.31 2.22 2.21 2.28 2.12 2.28 2.20 2.00 1.55 Receivable days 82.75 123.89 116.42 94.33 90.83 75.88 63.71 70.22 91.86 Inventory Days 24.50 29.30 33.13 24.52 25.15 25.97 21.92 19.22 19.28 Payable days 45.68 69.17 62.08 79.52 91.28 73.89 59.55 67.54 70.98 Cash Conversion Cycle 61.57 84.02 87.47 39.33 24.70 27.96 26.08 21.90 40.17 Total Debt/Equity 0.01 0.25 0.32 0.27 0.11 0.05 0.06 0.03 0.02 Interest Cover 76.75 8.59 8.81 14.58 48.48 119.10 54.58 30.75 17.10

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Syncom Formulations - Quarterly Results
13th Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback